Holen Sie sich die Stockscreener-App
328.34
1.26%
4.2018
Natera Inc Aktie (NTRA) Neueste Nachrichten
Jim Cramer Calls Natera (NTRA) “a Promising Story” - Yahoo Finance
Net current asset value per share of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA - TradingView
Fed. Circ. Urged To Overturn Natera's Cancer Test Patent Win - Law360
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia) - The Motley Fool
NTRA Initiated Coverage by Rothschild & Co -- Price Target Set a - GuruFocus
Can Natera (NTRA) Justify Its Valuation As Signatera Lymphoma Data Lifts Sentiment? - simplywall.st
Rothschild Redburn initiates Natera stock with buy on MRD leadership By Investing.com - Investing.com Nigeria
Rothschild Redburn initiates Natera stock with buy on MRD leadership - Investing.com
Debt to assets ratio of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRAD - TradingView
Net debt of NATERA INC CEDEAR EACH 51 REPR 1 COM (USD) – BCBA:NTRA.CI - tradingview.com
Natera, Inc. (NTRA) Stock Analysis: A $47.31 Billion Healthcare Innovator with Strong Buy Ratings - DirectorsTalk Interviews
Net income before discontinued operations of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRAD - TradingView
Diluted earnings per share (diluted EPS) of NATERA INC CEDEAR EACH 51 REPR 1 COM (USD) – BCBA:NTRA.CI - TradingView
Gross profit of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA - TradingView
NATERA INC CEDEAR EACH 51 REPR 1 COM (USD) Revenue Breakdown – BCBA:NTRA.CI - TradingView
Natera Inc Cert Deposito Arg Repr 0.019607 Sh Revenue Breakdown – BCBA:NTRA - TradingView
Guggenheim maintains Buy on Natera, raises target to $290 - scanx.trade
Net income before discontinued operations of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRAC - TradingView
The Bull Case For Natera (NTRA) Could Change Following New Signatera Lymphoma Data And Komen Partnership - simplywall.st
Natera CEO Steven Chapman sells $545k in NTRA shares By Investing.com - Investing.com South Africa
Natera president Solomon Moshkevich sells over $5.9m in shares By Investing.com - Investing.com South Africa
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years - Benzinga
Natera stock trades near 52-week high as guidance and regulatory wins support growth - AD HOC NEWS
Natera Inc (NTRA) CEO and President Steven Chapman Sells 1,698 S - GuruFocus
Natera president Solomon Moshkevich sells over $5.9m in shares - Investing.com
Natera CEO Steven Chapman sells $545k in NTRA shares - Investing.com
Natera (NASDAQ: NTRA) exec sells shares for taxes and under pre-set plan - Stock Titan
Natera Unlocks Broader Signatera Adoption With FDA, PMDA And NCCN Milestones! - smartkarma.com
Natera: $8.25M Prenatal Test Class Action Settlement Approved - Wansom AI
I would put Natera on my watch list and not chase the stock here, says Jim Cramer - CNBC
After recent stock sales, Natera (NASDAQ: NTRA) exec files notice to sell more shares - Stock Titan
Planned stock sale by Natera (NTRA) holder follows 41,124-share trade - Stock Titan
Natera (NASDAQ: NTRA) executive plans nearly $1M share sale after $2M in recent trades - Stock Titan
NTRA Looks 47.2% Overvalued on GF Value™ - GuruFocus
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma - Stock Titan
Natera teams with Angiex on cancer drug trial monitoring - Fierce Biotech
Pretax income of Natera, Inc. – LSX:A14VPJ - TradingView
Natera, Inc. (NTRA) Stock Analysis: A Healthcare Powerhouse with a 3.21% Upside Potential - DirectorsTalk Interviews
Natera Stock (NTRA) Opinions on Recent Price Surge - moomoo.com
Natera president John Fesko sells $2.1m in company stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ: NTRA) exec gets 20K RSUs, sells shares for taxes - Stock Titan
Natera & Angiex Partner to Evaluate AGX101 Response With Signatera - Eastern Progress
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer - finance.yahoo.com
Natera president John Fesko sells $2.1m in company stock - Investing.com
Natera partners with Angiex for cancer drug trial testing - Investing.com
Is Natera’s (NTRA) Kupando MRD Deal a Stepping Stone in Its Oncology Strategy? - simplywall.st
Natera: The Growth May Not Justify Current Levels - Seeking Alpha
Natera, Inc. (NTRA) Stock Analysis: A Healthcare Pioneer with 37.7% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Natera’s Oncology Push Has Wall Street Paying Up - Finimize
Natera Inc. Earnings Call Highlights Rapid Growth - TipRanks
Natera raises FY26 guidance to $2.85B-$2.91B after record Q2 volume - scanx.trade
Silvant Capital Management LLC Takes $12.32 Million Position in Natera, Inc. $NTRA - MarketBeat
Virtus Advisers LLC Takes $1.01 Million Position in Natera, Inc. $NTRA - MarketBeat
Ninepoint Partners LP Purchases New Position in Natera, Inc. $NTRA - MarketBeat
D L Carlson Investment Group Inc. Makes New $3.49 Million Investment in Natera, Inc. $NTRA - MarketBeat
Deutsche Bank AG Purchases Shares of 320,037 Natera, Inc. $NTRA - MarketBeat
Danske Bank A S Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Natera (NTRA) Earnings Snapshot: Profit Per Share Surpasses Its Benchmark; Price Reaction: The Stock Loses 0.07% at the CloseEPS Guidance Update - vinanet.vn
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? - AOL.com
Natera stock reaches all-time high at 326.26 USD By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Natera stock reaches all-time high at 326.26 USD - Investing.com
Natera (NTRA) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Latest Reaction - vinanet.vn
Mitsubishi UFJ Asset Management Co. Ltd. Takes $50.42 Million Position in Natera, Inc. $NTRA - MarketBeat
1.62%
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):